Generate a tailored SOP for Dr. Jennifer Klomp. Improve your application with a focused, well-structured draft.
Jennifer Klomp completed her PhD at the University of Illinois Chicago, where she developed tools to study the Src proto-oncogene. Her subsequent work has focused on understanding the role of aberrant kinase activity in KRAS mutant cancers and how they can be exploited therapeutically. She is currently identifying how the ERK kinase supports pancreatic cancer cell growth using a combination of transcriptomics, phosphoproteomics, engineered kinases, and functional genetic screens. Jennifer Klomp has been awarded postdoctoral fellowships from the National Cancer Institute (F32 K99/R00) and the American Cancer Society.
Michigan State University • Grand Rapids
Conducts research in the Department of Medicine.
Department of Psychology